Which condition is an indication for thrombolytic therapy with Alteplase?

Prepare for the Chronic Illness Test. Use a variety of study tools including flashcards and quiz questions, with helpful hints and thorough explanations. Ensure your success on exam day!

Multiple Choice

Which condition is an indication for thrombolytic therapy with Alteplase?

Explanation:
Alteplase is a tissue plasminogen activator that dissolves clots by converting plasminogen to plasmin, which breaks down fibrin. This makes it useful when a clot-blocked vessel needs to be opened quickly to restore blood flow. In acute myocardial infarction, a coronary artery is occluded by a thrombus, and thrombolysis aims to rapidly reopen the artery to preserve heart muscle and reduce damage. This is a classic, time-sensitive indication for systemic thrombolytic therapy when primary PCI isn’t available promptly. Preventing deep vein thrombosis is not achieved with thrombolytics; prevention relies on anticoagulants and mechanical measures. Restoring catheter patency can involve catheter-directed thrombolysis, which is a different, targeted use rather than systemic therapy for an acute MI. So the scenario that clearly fits the standard indication for systemic alteplase is treating an acute myocardial infarction.

Alteplase is a tissue plasminogen activator that dissolves clots by converting plasminogen to plasmin, which breaks down fibrin. This makes it useful when a clot-blocked vessel needs to be opened quickly to restore blood flow. In acute myocardial infarction, a coronary artery is occluded by a thrombus, and thrombolysis aims to rapidly reopen the artery to preserve heart muscle and reduce damage. This is a classic, time-sensitive indication for systemic thrombolytic therapy when primary PCI isn’t available promptly.

Preventing deep vein thrombosis is not achieved with thrombolytics; prevention relies on anticoagulants and mechanical measures. Restoring catheter patency can involve catheter-directed thrombolysis, which is a different, targeted use rather than systemic therapy for an acute MI. So the scenario that clearly fits the standard indication for systemic alteplase is treating an acute myocardial infarction.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy